The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Pearson Andrea | Director | Grant(A) | 852 | — | $0 |
| Feb 24, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Sell(S) | 11K | $28.94 | $318K |
| Feb 24, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 6K | $28.94 | $181K |
| Feb 24, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell(S) | 8K | $28.94 | $223K |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Sell(S) | 15K | $28.28 | $416K |
| Feb 23, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Sell(S) | 537 | $28.69 | $15K |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 4K | $28.28 | $121K |
| Feb 23, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 160 | $28.69 | $5K |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell(S) | 5K | $28.28 | $151K |
| Feb 23, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Sell(S) | 196 | $28.69 | $6K |
| Feb 20, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 28K | — | $0 |
| Feb 20, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 20K | — | $0 |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 7K | — | $0 |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 4K | — | $0 |
| Feb 20, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 3K | — | $0 |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Grant(A) | 4K | — | $0 |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Grant(A) | 7K | — | $0 |
| Feb 20, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Grant(A) | 16K | — | $0 |
| Feb 19, 2026 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 49K | — | $0 |
| Feb 19, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 6K | — | $0 |
| Feb 19, 2026 | Birkemeyer Elaine M. | CHIEF FINANCIAL OFFICER | Grant(A) | 23K | — | $0 |
| Jan 2, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 5K | $28.85 | $148K |
| Aug 8, 2025 | Dodd Sheri Louise | Chief Executive Officer, Director | Sell(S) | 8K | $12.36 | $96K |
| May 12, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell(S) | 3K | $9.94 | $29K |
| May 8, 2025 | Burke William W | Director | Sell(S) | 3K | $9.67 | $32K |
| May 8, 2025 | Dodd Sheri Louise | Chief Executive Officer, Director | Sell(S) | 3K | $9.83 | $31K |
| May 7, 2025 | Washington Boyd Vindell | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | Volkart Carmen B | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | Shafer David Brent | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | King Laura G. | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | Huggenberger Raymond | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | Asbury Valerie L. | Director | Grant(A) | 16K | — | $0 |
| May 7, 2025 | Burke William W | Director | Grant(A) | 16K | — | $0 |
| Mar 11, 2025 | Reuvers Daniel L. | Director | Gift(G) | 68K | — | $0 |
| Mar 11, 2025 | Reuvers Daniel L. | Director | Gift(G) | 68K | — | $0 |
| Feb 25, 2025 | Reuvers Daniel L. | Director | Sell(S) | 28K | $14.18 | $402K |
| Feb 25, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 6K | $14.40 | $93K |
| Feb 25, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell(S) | 2K | $14.51 | $30K |
| Feb 24, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell(S) | 4K | $14.70 | $56K |
| Feb 24, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 5K | $14.65 | $71K |
| Feb 24, 2025 | Reuvers Daniel L. | Director | Sell(S) | 11K | $14.55 | $159K |
| Feb 20, 2025 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 20K | — | $0 |
| Feb 20, 2025 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 66K | — | $0 |
| Feb 20, 2025 | King Laura G. | Director | Grant(A) | 3K | — | $0 |
| Feb 20, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Grant(A) | 36K | — | $0 |
| Feb 20, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Grant(A) | 3K | — | $0 |
| Feb 20, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Grant(A) | 7K | — | $0 |
| Feb 20, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 17K | — | $0 |
| Feb 20, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 3K | — | $0 |
| Feb 20, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 4K | — | $0 |
| Feb 20, 2025 | Reuvers Daniel L. | Director | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Ferstler Sherri Lee | Senior VP, Sales | Sell(S) | 2K | $13.07 | $20K |
| Aug 7, 2024 | Dodd Sheri Louise | Chief Executive Officer, Director | Grant(A) | 65K | — | $0 |
| May 16, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Sell(S) | 3K | $13.68 | $42K |
| May 8, 2024 | Washington Boyd Vindell | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Volkart Carmen B | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Shafer David Brent | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Huggenberger Raymond | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Dodd Sheri Louise | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Asbury Valerie L. | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Burke William W | Director | Grant(A) | 10K | — | $0 |
| May 8, 2024 | Burke William W | Director | Sell(S) | 3K | $14.06 | $35K |
| May 6, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 815 | $14.37 | $12K |
| Feb 29, 2024 | Reuvers Daniel L. | President and CEO, Director | Sell(S) | 1K | $15.25 | $21K |
| Feb 29, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 243 | $15.25 | $4K |
| Feb 27, 2024 | Reuvers Daniel L. | President and CEO, Director | Sell(S) | 5K | $15.60 | $73K |
| Feb 27, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 1K | $15.58 | $17K |
| Feb 26, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 2K | $15.91 | $32K |
| Feb 26, 2024 | Reuvers Daniel L. | President and CEO, Director | Sell(S) | 6K | $15.81 | $99K |
| Feb 24, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Grant(A) | 3K | — | $0 |
| Feb 24, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 3K | — | $0 |
| Feb 24, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 9K | — | $0 |
| Feb 24, 2024 | Reuvers Daniel L. | President and CEO, Director | Grant(A) | 13K | — | $0 |
| Feb 24, 2024 | Reuvers Daniel L. | President and CEO, Director | Grant(A) | 45K | — | $0 |
| Feb 23, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell(S) | 2K | $14.80 | $33K |
| Feb 23, 2024 | Reuvers Daniel L. | President and CEO, Director | Sell(S) | 5K | $14.85 | $80K |
| Feb 21, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Grant(A) | 32K | — | $0 |
| Feb 21, 2024 | Ferstler Sherri Lee | Senior VP, Sales | Grant(A) | 22K | — | $0 |
| Feb 21, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Grant(A) | 19K | — | $0 |
| Feb 21, 2024 | Reuvers Daniel L. | President and CEO, Director | Grant(A) | 72K | — | $0 |
| Nov 8, 2023 | Washington Boyd Vindell | Director | Grant(A) | 9K | — | $0 |
| Aug 9, 2023 | Ferstler Sherri Lee | Senior VP, Sales | Grant(A) | 19K | — | $0 |
| Aug 7, 2023 | Reuvers Daniel L. | President and CEO, Director | Sell(S) | 1K | $20.53 | $22K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).